Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: The HIFMECH study

Atherosclerosis

Volumn 179, Issue 2, 2005, Pages 317-323

  Morange, P E ^a   Saut, N ^a   Alessi, M C ^a   Frere, C ^a   Hawe, E ^b   Yudkin, J S ^b   Tremoli, E ^c   Margaglione, M ^d   Di Minno, G ^d   Hamsten, A ^e   Humphries, S E ^b   Juhan Vague, I ^a  

^a TIMONE HOSPITAL   (France)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immune system; Inflammation; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 20144365771     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.10.014     Document Type: Article

References (27)

1. R. Medzhitov, and C. Janeway Jr. Innate immunity N Engl J Med 343 2000 338 344
2. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
3. M. Baldini, I.C. Lohman, and M. Halonen A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E Am J Respir Cell Mol Biol 20 1999 976 983
4. T.D. LeVan, J.W. Bloom, and T.J. Bailey A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity J Immunol 167 2001 5838 5844
5. J.A. Hubacek, G. Rothe, and J. Pit'ha C(-260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction Circulation 99 1999 3218 3220
6. W. Koenig, N. Khuseyinova, and M.M. Hoffmann CD14 C(-260) → T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease J Am Coll Cardiol 40 2002 34 42
7. K. Unkelbach, A. Gardemann, and M. Kostrzewa A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile Arterioscler Thromb Vasc Biol 19 1999 932 938
8. K. Shimada, Y. Watanabe, and H. Mokuno Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men Am J Cardiol 86 2000 682 684 [A8]
9. H. Elghannam, S. Tavackoli, and L. Ferlic A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy J Mol Med 78 2000 562 568
10. R.Y. Zee, K. Lindpaintner, B. Struk, C.H. Hennekens, and P.M. Ridker A prospective evaluation of the CD14 C(-260) T-gene polymorphism and the risk of myocardial infarction Atherosclerosis 154 2001 699 702
11. W. Koch, A. Kastrati, J. Mehilli, N. von Beckerath, and A. Schomig CD14 gene-159C/T polymorphism is not associated with coronary artery disease and myocardial infarction Am Heart J 143 2002 971 976
12. M. Nauck, B.R. Winkelmann, and M.M. Hoffmann C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study Am J Cardiol 90 2002 1249 1252
13. C.J.C.M. Binder, P.X. Shaw, and Y.I. Miller Innate and acquired immunity in atherogenesis Nat Med 8 2002 1218 1226
14. I. Juhan-Vague, P.E. Morange, and H. Aubert Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe Arterioscler Thromb Vasc Biol 22 2002 867 873
15. S.A.D.D. Miller, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1988 1215
16. M.P. de Maat, H. Pijl, C. Kluft, and H.M. Princen Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals Eur J Clin Nutr 54 2000 757 763
17. J.S. Yudkin, I. Juhan-Vague, and E. Hawe Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study Metabolism 53 2004 852 857
18. G.K. Hansson, P. Libby, U. Schonbeck, and Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
19. K.G. Jones, D.J. Brull, and L.C. Brown Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms Circulation 103 2001 2260 2265
20. D.J. Brull, H.E. Montgomery, and J. Sanders Interleukin-6 gene-174G > C and -572G > C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery Arterioscler Thromb Vasc Biol 21 2001 1458 1463
21. P.M. Ridker, N. Rifai, M.J. Stampfer, and C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
22. F. Basso, G.D. Lowe, A. Rumley, A.D. McMahon, and S.E. Humphries Interleukin-6-174G > C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS) Arterioscler Thromb Vasc Biol 22 2002 599 604
23. F. Andreotti, I. Porto, F. Crea, and A. Maseri Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies Heart 87 2002 107 112
24. K.A. Zarember, and P.J. Godowski Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines J Immunol 168 2002 554 561
25. H. Gierens, M. Nauck, and M. Roth lnterleukin-6 stimulates LDL receptor gene expression via activation of sterol- responsive and Spl binding elements Arterioscler Thromb Vasc Biol 20 2000 1777 1783
26. J.S. Forrester Prevention of plaque rupture: a new paradigm of therapy Ann Intern Med 137 2002 823 833
27. L. Tiret, P. de Knijff, and H.J. Menzel ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations The EARS Study. European Atherosclerosis Research Study Arterioscler Thromb 14 1994 1617 1624